STATE STREET CORP - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,850,669
+4.7%
1,317,801
+9.4%
0.00%0.0%
Q2 2023$21,833,513
+182.9%
1,204,940
+315.4%
0.00%
Q1 2023$7,716,687
-23.5%
290,101
-44.4%
0.00%
Q4 2022$10,083,494
+126.0%
521,650
+144.2%
0.00%
Q3 2022$4,462,000
+551.4%
213,581
+149.9%
0.00%
Q2 2022$685,000
-78.1%
85,468
-80.9%
0.00%
Q1 2022$3,133,000
-47.8%
446,996
+0.5%
0.00%
Q4 2021$6,002,000
-14.9%
444,629
+6.4%
0.00%
Q3 2021$7,056,000
-37.1%
418,003
+8.6%
0.00%
-100.0%
Q2 2021$11,211,000
-25.0%
385,008
+1.3%
0.00%0.0%
Q1 2021$14,955,000
+263.7%
380,249
+110.1%
0.00%
Q4 2020$4,112,000
+51.0%
180,991
+50.6%
0.00%
Q3 2020$2,723,000120,2070.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP III, LLC 1,839,160$35,550,96327.86%
TRV GP IV, LLC 2,132,867$41,228,31917.53%
CHI Advisors LLC 3,169,892$61,274,01216.32%
GREAT POINT PARTNERS LLC 1,322,870$25,571,0775.01%
VR Adviser, LLC 1,080,000$20,876,4003.52%
Redmile Group, LLC 3,878,599$74,973,3193.07%
Casdin Capital, LLC 1,675,000$32,377,7502.51%
Fernwood Investment Management, LLC 304,573$5,887,3962.44%
Cheyne Capital Management (UK) LLP 66,144$1,278,5642.23%
First Light Asset Management, LLC 1,057,881$20,448,8401.90%
View complete list of PLIANT THERAPEUTICS INC shareholders